Experienced in Hives

Anna Sohn

Mainz, RP, DE 
Experienced in Hives
Mainz, RP, DE 
OverviewLocationsClinical Research

Overview

Anna Sohn practices in Mainz, Germany. Ms. Sohn is rated as an Experienced expert by MediFind in the treatment of Hives. Her top areas of expertise are Punctate Porokeratosis, Hives, and Atopic Dermatitis.

Her clinical research consists of co-authoring 9 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles and participated in 2 clinical trials in the study of Hives.

Gender
Female

Locations

Mainz, RP, Germany
Other Locations
Frankfurt Am Main, HE 60590, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Proof of Concept, Multicenter, 16-week Treatment Study With a 16 Week Follow-up Period to Assess the Efficacy and Safety of Dupilumab (Anti-IL4Ra) in Adult Patients With Cholinergic Urticaria Despite H1-antihistamine Treatment
A Randomized, Double-blind, Placebo-controlled, Proof of Concept, Multicenter, 16-week Treatment Study With a 16 Week Follow-up Period to Assess the Efficacy and Safety of Dupilumab (Anti-IL4Ra) in Adult Patients With Cholinergic Urticaria Despite H1-antihistamine Treatment
Enrollment Status: Completed
Publish Date: September 06, 2023
Intervention Type: Drug
Study Drug: Dupilumab
Study Phase: Phase 2
A Multicenter, Randomized, Double-blind, Placebo-controlled, Proof-of-concept Phase 2, 16-week Treatment Study With a 16 Week Follow-up Period to Assess the Efficacy and Safety of Dupilumab (Anti-IL4Ra) in Adult Patients With Chronic Spontaneous Urticaria Despite H1-antihistamine Treatment.
A Multicenter, Randomized, Double-blind, Placebo-controlled, Proof-of-concept Phase 2, 16-week Treatment Study With a 16 Week Follow-up Period to Assess the Efficacy and Safety of Dupilumab (Anti-IL4Ra) in Adult Patients With Chronic Spontaneous Urticaria Despite H1-antihistamine Treatment.
Enrollment Status: Completed
Publish Date: February 02, 2022
Intervention Type: Drug
Study Drug: Dupilumab
Study Phase: Phase 2
View 1 Less Clinical Trial

9 Total Publications

Midwives as influencers in skin care for newborns at risk of atopic diseases : Survey of midwives' current recommendations
Midwives as influencers in skin care for newborns at risk of atopic diseases : Survey of midwives' current recommendations
Journal: Dermatologie (Heidelberg, Germany)
Published: March 18, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Sohn's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile